|
|
|
|
pmid:
|
Dubé MP et al. |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. |
1999 |
Clin. Infect. Dis. |
pmid:10028084
|
Goh KL et al. |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10029275
|
Horgen L et al. |
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium. |
1999 |
FEMS Immunol. Med. Microbiol. |
pmid:10030545
|
Sakurai K et al. |
[Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori]. |
1999 |
Nippon Rinsho |
pmid:10036938
|
Fukazawa K et al. |
[Antimicrobial resistance testing of H. pylori epsilometer test and disk diffusion test]. |
1999 |
Nippon Rinsho |
pmid:10036939
|
Murakami K and Kimoto M |
[Antibiotic-resistant H. pylori strains in the last ten years in Japan]. |
1999 |
Nippon Rinsho |
pmid:10036940
|
Maeda S and Yoshida H |
[Detection of Helicobacter pylori 23S rRNA gene mutation associated with clarithromycin resistance and its clinical applicability]. |
1999 |
Nippon Rinsho |
pmid:10036941
|
Sekine H et al. |
[Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment]. |
1999 |
Nippon Rinsho |
pmid:10036947
|
Iwasaki A |
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy]. |
1999 |
Nippon Rinsho |
pmid:10036949
|
Habu Y et al. |
[Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease]. |
1999 |
Nippon Rinsho |
pmid:10036950
|
Shirai T et al. |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer]. |
1999 |
Nippon Rinsho |
pmid:10036951
|
Nakagawa M et al. |
[A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer]. |
1999 |
Nippon Rinsho |
pmid:10036952
|
Kihira K et al. |
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections]. |
1999 |
Nippon Rinsho |
pmid:10036953
|
Goto T et al. |
[Erosive duodenitis after eradication therapy for Helicobacter pylori]. |
1999 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:10047687
|
Wang G et al. |
Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10049289
|
Woo PC et al. |
Clarithromycin attenuates the inflammatory response induced by surgical trauma in a guinea pig model. |
1999 |
Pharmacol. Res. |
pmid:10051377
|
Kistler A et al. |
Therapeutic dilemma: crescentic mesangiocapillary glomerulonephritis type 1 in a patient on antituberculous therapy with rifampicin. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10052525
|
Yan JJ et al. |
Disseminated Mycobacterium genavense infection in a patient with acquired immunodeficiency syndrome: first case report in Taiwan. |
1999 |
J. Formos. Med. Assoc. |
pmid:10063276
|
Keto Y et al. |
Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin. |
1999 |
Dig. Dis. Sci. |
pmid:10063909
|
Nilsson F and Walder M |
[Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance]. |
1999 |
Lakartidningen |
pmid:10064930
|
Sato K and Tomioka H |
[In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo]. |
1999 |
Kekkaku |
pmid:10067057
|
Schultz-Süchting F et al. |
Treatment of Helicobacter heilmannii-associated gastritis in a 14-year-old boy. |
1999 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10067743
|
Vásconez C et al. |
Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. |
1999 |
J. Hepatol. |
pmid:10068106
|
Dehesa M et al. |
[Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer]. |
1998 Apr-Jun |
Rev Gastroenterol Mex |
pmid:10068730
|
Yajima T et al. |
Optimum spray congealing conditions for masking the bitter taste of clarithromycin in wax matrix. |
1999 |
Chem. Pharm. Bull. |
pmid:10071855
|
Owen RJ |
Helicobacter pylori resists arrest. |
1999 |
Gut |
pmid:10075942
|
Marais A et al. |
Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. |
1999 |
Gut |
pmid:10075951
|
Shirtliff ME et al. |
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. |
1999 |
Clin. Orthop. Relat. Res. |
pmid:10078148
|
Periti P and Mazzei T |
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. |
1999 |
J Chemother |
pmid:10078776
|
de Jong JJ et al. |
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient. |
1999 |
Transpl. Int. |
pmid:10080410
|
Woo MS et al. |
Pediatric transplant grand rounds. A case presentation: skin lesions in a post-lung transplant patient. |
1997 |
Pediatr Transplant |
pmid:10084776
|
Moreau P et al. |
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM) |
1999 |
Leukemia |
pmid:10086745
|
Unge P |
Antibiotic treatment of Helicobacter pylori infection. |
1999 |
Curr. Top. Microbiol. Immunol. |
pmid:10087665
|
Wreiber K et al. |
[Development of resistant Helicobacter pylori in Sweden. Tendency toward increasing resistance to clarithromycin]. |
1999 |
Lakartidningen |
pmid:10087796
|
Sakatani M |
[Multi-drug resistant mycobacterial infection]. |
1999 |
Ryoikibetsu Shokogun Shirizu |
pmid:10088372
|
GarcÃa-Romero E et al. |
[Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer]. |
1999 |
Gastroenterol Hepatol |
pmid:10089703
|
Ramirez J et al. |
Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia. |
1999 |
Clin Ther |
pmid:10090428
|
Ong EL |
Prophylaxis against disseminated Mycobacterium avium complex in AIDS. |
1999 |
J. Infect. |
pmid:10090497
|
Sunazuka T et al. |
Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells. |
1999 |
J. Antibiot. |
pmid:10092202
|
Talley NJ et al. |
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. |
1999 |
BMJ |
pmid:10092259
|
Khoo KH et al. |
Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex. |
1999 |
J. Biol. Chem. |
pmid:10092667
|
Torgano G et al. |
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. |
1999 |
Circulation |
pmid:10096930
|
Navuluri R and Yue S |
Understanding peptic ulcer disease pharmacotherapeutics. |
1999 |
Nurse Pract |
pmid:10100245
|
Tirén U et al. |
Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. |
1999 |
Acta Paediatr. |
pmid:10102149
|
Graham DY et al. |
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102946
|
Zanten SJ et al. |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102960
|
Van der Wouden EJ et al. |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102961
|
Wong BC et al. |
Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102962
|
Xiao SD et al. |
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102963
|
Liu WZ et al. |
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102964
|
Huang J and Hunt RH |
Clarithromycin-based triple therapies. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102978
|
Kohyama T et al. |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103198
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|
Craig AM et al. |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin. |
1996 |
Pharmacoeconomics |
pmid:10160472
|
Gimenez Garcia R et al. |
Fish tank granuloma: response to treatment with clarithromycin. |
1999 |
J Eur Acad Dermatol Venereol |
pmid:10188167
|
Fournier S et al. |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192709
|
Gómez-Gil E et al. |
Clarithromycin-induced acute psychoses in peptic ulcer disease. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192720
|
Rosário M et al. |
[Profile of the resistance to macrolides and imidazoles of Helicobacter pylori in a sample of the Portuguese population]. |
1998 |
Acta Med Port |
pmid:10192979
|
Lee CK et al. |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. |
1999 |
Vaccine |
pmid:10195786
|
Verbanck JJ et al. |
Campylobacter jejuni II peritonitis in a CCPD patient: cure by oral clarithromycin. |
1999 Jan-Feb |
Perit Dial Int |
pmid:10201350
|
Sonnenberg A et al. |
The effect of antibiotic therapy on bleeding from duodenal ulcer. |
1999 |
Am. J. Gastroenterol. |
pmid:10201462
|
Smoot DT et al. |
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10201463
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Zhou Q et al. |
CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin. |
1999 |
Eur. J. Clin. Pharmacol. |
pmid:10206083
|
Miwa H et al. |
Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10207779
|
Henry DC et al. |
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group. |
1999 |
Clin Ther |
pmid:10211537
|
McConnell SA and Amsden GW |
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. |
1999 |
Pharmacotherapy |
pmid:10212011
|
Dubois J and St-Pierre C |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10212753
|
Clifford K et al. |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. |
1999 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10214783
|
Kashimura H et al. |
Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215732
|
Lee JM et al. |
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215733
|
Neville PM et al. |
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215734
|
Hoffman JS et al. |
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215735
|
Abbott GW et al. |
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. |
1999 |
Cell |
pmid:10219239
|
van der Hulst RW et al. |
[Treatment of Helicobacter pylori infections]. |
1999 |
Ned Tijdschr Geneeskd |
pmid:10221109
|
Khan AA et al. |
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10221415
|
Sato K and Tomioka H |
Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells. |
1999 |
J. Antimicrob. Chemother. |
pmid:10223590
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Fish DN and Abraham E |
Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223952
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|
Gisbert JP et al. |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments]. |
1999 |
Med Clin (Barc) |
pmid:10227015
|
Gisbert JP |
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy]. |
1999 |
Rev Esp Enferm Dig |
pmid:10231305
|
Goddard AF et al. |
Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10233187
|
Pilotto A et al. |
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10233191
|
Hayashi Y et al. |
Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia. |
1999 |
Pacing Clin Electrophysiol |
pmid:10234723
|
Vakil N and Cutler A |
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10235192
|
Woods GL et al. |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. |
1999 |
J. Clin. Microbiol. |
pmid:10325306
|
Warheker PT et al. |
Successful treatment of saccular endophthalmitis with clarithromycin. |
1998 |
Eye (Lond) |
pmid:10326009
|
Carbon C and Poole MD |
The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data. |
1999 |
J Chemother |
pmid:10326741
|
Le Gars L et al. |
Polyarthralgia-arthritis syndrome induced by low doses of rifabutin. |
1999 |
J. Rheumatol. |
pmid:10332992
|
Bocheńska-Marciniak M et al. |
[Clinical efficacy and safety of spiramycin and clarithromycin in the treatment of outpatients with lower respiratory tract infections]. |
1998 |
Pol. Arch. Med. Wewn. |
pmid:10335027
|
Champney WS and Tober CL |
Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. |
1999 |
Curr. Microbiol. |
pmid:10341075
|
Nitu IC et al. |
Management of liver failure in a haemophilic patient co-infected with human immunodeficiency and hepatitis C viruses. |
1999 |
Clin Lab Haematol |
pmid:10342075
|
Abdul Aal GM et al. |
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week. |
1999 |
Digestion |
pmid:10343145
|
Dajani AI et al. |
One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases. |
1999 |
Digestion |
pmid:10343146
|
Sonnenberg A et al. |
Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer. |
1999 |
Am J Manag Care |
pmid:10345967
|
Champney WS and Tober CL |
Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348746
|
Debets-Ossenkopp YJ et al. |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. |
1999 |
J. Antimicrob. Chemother. |
pmid:10350380
|
Son SW et al. |
The response of rosacea to eradication of Helicobacter pylori. |
1999 |
Br. J. Dermatol. |
pmid:10354058
|